Shareholders' Equity (Deficit) - Narrative (Details) - USD ($) shares in Millions |
1 Months Ended | 3 Months Ended | |||||
---|---|---|---|---|---|---|---|
Feb. 28, 2022 |
Nov. 30, 2020 |
Jun. 30, 2017 |
Nov. 30, 2014 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Apr. 30, 2012 |
|
Share Repurchase Program [Line Items] | |||||||
Share repurchase authorization amount | $ 27,500,000,000 | $ 5,000,000,000.0 | |||||
Share repurchase authorization amount, increase during period | $ 7,500,000,000 | $ 5,000,000,000.0 | $ 5,000,000,000.0 | $ 5,000,000,000.0 | |||
Shares purchased (in shares) | 0.6 | 0.8 | |||||
Total cost of shares purchased | $ 250,000,000 | $ 250,000,000 | |||||
Antidilutive securities excluded from computation of earnings per share (in shares) | 0.1 | ||||||
Repurchase Program | |||||||
Share Repurchase Program [Line Items] | |||||||
Share repurchase, remaining authorized repurchase amount | $ 2,100,000,000 | ||||||
Shares purchased (in shares) | 172.8 | ||||||
Total cost of shares purchased | $ 25,400,000,000 |